| |
|
|
|
|
|
 |
| |
|
°³ºñ½ºÄÜÆäÆÛ¹ÎÆ®ÇöŹ¾× 10mL Gaviscon Peppermint Suspension
|
|
ÀϹÝÀǾàǰ | ºñ±Þ¿©
|
|
¼öÀÔÀǾàǰ
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦
ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î
·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
|
|
|
 | Çã°¡Á¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå »óÇÑ±Ý¾× |
640600021[640600020]
[º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸]
[ºñ±Þ¿©]
[»óº´ÄÚµåÁ¶È¸]
[Áúº´ÄÚµåÁ¶È¸]
|
| ºü¸¥Á¶È¸ |
|
| Á¦Ç°¼º»ó |
ÆäÆÛ¹ÎÆ®ÇâÀÌ ³ª´Â ¹ÌȲ»ö~Å©¸²»öÀÇ Á¡Á¶¼º ÇöŹ¾× [Á¦ÇüÁ¤º¸ È®ÀÎ] |
| Æ÷À塤À¯Åë´ÜÀ§ |
10ml/Æ÷ x 4Æ÷,12Æ÷, 150ml/1º´ |
| ÁÖ¼ººÐÄÚµå |
E45600ASS
[µ¿ÀÏÇÑ ÁÖ¼ººÐÄڵ带 °¡Áø ¿À¸®Áö³¯ ¶Ç´Â Á¦³×¸¯ ÀǾàǰ Á¶È¸]
|
| Çã°¡»çÇ× ¿ø¹®Á¶È¸ |
[Çã°¡»çÇ× ¿ø¹®Á¶È¸]
|
| È¿´ÉÈ¿°ú |
[ÀûÀÀÁõ º° °Ë»ö]
´ÙÀ½ÀÇ À§½Äµµ ¿ª·ùÀÇ Áõ»ó °³¼± :
¡Û »ê ¿ª·ù
¡Û ¼Ó¾²¸²
¡Û À§ ³»¿ë¹°ÀÇ ¿ª·ù·Î ÀÎÇÑ ¼ÒȺҷ® (¿¹¸¦ µé¾î ½Ä»ç ÈÄ, ÀӽŠÁß, ¿ª·ù¼º ½Äµµ¿°°ú µ¿¹ÝÇÏ´Â °æ¿ìÀÇ)
|
| ¿ë¹ý¿ë·® |
* Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù.
[󹿾à¾î]
¼ºÀÎ : 1ȸ 10 ¢¦ 20 mLÀ» 1ÀÏ 4ȸ(½ÄÈÄ ¹× ÃëħÀü) º¹¿ëÇÑ´Ù.
|
| ±Ý±â |
ÀÌ ¾à ¶Ç´Â ÀÌ ¾à ±¸¼º¼ººÐ¿¡ °ú¹Î¹ÝÀÀÀÌ ÀÖ´Â »ç¶÷ |
| ½ÅÁßÅõ¿© |
1) ¿ïÇ÷½ÉºÎÀü, ½ÅÀå¾Ö µî°ú °°ÀÌ ³ªÆ®·ýÀ» ¸Å¿ì Á¦ÇÑÇØ¾ß Çϴ ȯÀÚ(ÀÌ ¾àÀº 10 mL´ç 141 mg(6.2 mmoL)ÀÇ ³ªÆ®·ýÀ» ÇÔÀ¯)
2) °íÄ®½·Ç÷Áõ, ½Å¼®È¸Ä§ÂøÁõ(nephrocalcinosis)°ú Àç¹ß¼º Ä®½·ÇÔÀ¯ ½Å°á¼®(recurrent calcium containing renal calculi) ȯÀÚ(ÀÌ ¾àÀº 10 mL´ç 160 mg(1.6 mmoL)ÀÇ Åº»êÄ®½·À» ÇÔÀ¯)
3) 12¼¼ ¹Ì¸¸ÀÇ ¾î¸°ÀÌ¿¡ ´ëÇÑ º¹¿ëÀº ÀÇ»çÀÇ Áö½Ã°¡ ¾Æ´Ï¸é ÀϹÝÀûÀ¸·Î ÃßõµÇÁö ¾Ê´Â´Ù. |
| ÀÌ»ó¹ÝÀÀ |
´ÙÀ½°ú °°Àº °æ¿ì ÀÌ ¾àÀÇ º¹¿ëÀ» Áï°¢ ÁßÁöÇϰí ÀÇ»ç, Ä¡°úÀÇ»ç, ¾à»ç¿Í »óÀÇÇÒ °Í. »ó´ã½Ã °¡´ÉÇÑÇÑ ÀÌ Ã·ºÎ¹®¼¸¦ ¼ÒÁöÇÒ °Í.
1) ÀÌ ¾à¿¡ ¹Î°¨ÇÑ ¸Å¿ì ±Ø¼Ò¼öÀÇ(< 1/10,000)ȯÀÚ¿¡°Ô¼ °¡·Á¿òÀ̳ª ±â°üÁö ¼öÃà, ¾Æ³ªÇʶô½Ã½º ¹ÝÀÀ°ú °°Àº ¾Ë·¹¸£±â ¹ÝÀÀÀÌ ³ªÅ¸³ª´Â °æ¿ì
2) °¡²û ¼³»ç, º¯ºñ µîÀÇ Áõ»óÀÌ ÀÖÀ» ¼ö ÀÖ´Ù.
3) Åõ¾à 7ÀÏ ÈÄ¿¡µµ Áõ»óÀÌ °³¼±µÇÁö ¾ÊÀ» °æ¿ì
|
| »óÈ£ÀÛ¿ë |
Á¦»êÁ¦ÀΠź»êÄ®½·ÀÇ ÀÛ¿ëÀÌ ÀÖÀ¸¹Ç·Î ´Ù¸¥ ¾à¹°°ú 2½Ã°£ÀÇ °£°ÝÀ» µÎ°í º¹¿ëÇÒ °Í(¿¹, Åׯ®¶ó»çÀÌŬ¸°, µð°î½Å, Ç÷ç¿À·ÎÄû³î·Ð, ö¿°(Iron salt), ÄÉÅäÄÚ³ªÁ¹, ½Å°æÀÌ¿ÏÁ¦(neuroleptics), Ƽ·Ï½Å, Æä´Ï½Ç¶ó¹Î, º£Å¸Â÷´ÜÁ¦(¾ÆÅ׳î¿Ã, ¸ÞÅäÇÁ·Î·Ñ, ÇÁ·ÎÇÁ¶ó³î·Ñ), ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀ̵å, Ŭ·Î·ÎÄý, ¿¡½ºÆ®¶ó¹«½ºÆ¾ ¹× µðÆ÷½ºÆ÷³×ÀÌÆ®(diphosphonates). |
| Off-label Usage |
[Á¶È¸]
|
| Related FDA Approved Drug |
±âÁØ ¼ººÐ: SODIUM BICARBONATEBAROS (SODIUM BICARBONATE; TARTARIC ACID)
BSS PLUS (CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE)
CO-LAV (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
COLOVAGE (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
COLYTE (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
COLYTE WITH FLAVOR PACKS (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
COLYTE-FLAVORED (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
ELLIOTTS B SOLUTION (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE)
ENDOSOL EXTRA (CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE)
E-Z-EM PREP LYTE (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
GLYCOPREP (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
GO-EVAC (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
GOLYTELY (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
HALFLYTELY (BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
NAVSTEL (CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE)
NORMOCARB HF 25 (MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
NORMOCARB HF 35 (MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
NULYTELY (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
NULYTELY-FLAVORED (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
OCL (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE)
PEG 3350 AND ELECTROLYTES (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PEG-LYTE (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS)
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 2/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 4/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BK 0/0 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
SODIUM BICARBONATE (SODIUM BICARBONATE)
SODIUM BICARBONATE IN PLASTIC CONTAINER (SODIUM BICARBONATE)
TRILYTE (POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE)
ZEGERID (MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE)
±âÁØ ¼ººÐ: PRECIPITATED CALCIUM CARBONATE±âÁØ ¼ººÐ: ARGININE SODIUM
|
|
|
 | Á¤º¸¿ä¾à |
|
|
|
µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
|
|
 | ÄÚµå ¹× ºÐ·ùÁ¤º¸ |
|
|
| |
|
 | Á¦Ç°Á¤º¸ |
|
|
|
|
 | º¹¾àÁ¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
| LACTmed ¹Ù·Î°¡±â |
[¹Ù·Î°¡±â]
|
| ¾à¸®ÀÛ¿ë |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| º¹¾àÁöµµ |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| ÀӺο¡´ëÇÑÅõ¿© |
| * |
ÀüüÀӽŠ±â°£º°·Î ¿©·¯µî±ÞÀÌ Á¸ÀçÇÒ ¼ö ÀÖÀ¸¸ç °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ º¸¿©Áý´Ï´Ù. ´Ü, º¹ÇÕÁ¦ÀÇ °æ¿ì ¸ðµç º¹ÇÕÁ¦¼ººÐ¿¡ ´ëÇÑ ÀÓºÎÅõ¿©µî±ÞÀÌ Ç¥½ÃµÈ°ÍÀº Àý´ë ¾Æ´Ï¸ç Ç¥½ÃµÈ°ÍÁß¿¡ °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ ³ªÅ¸³³´Ï´Ù.
|
|
|   |
 FDA : Cµî±Þ
(sodium bicarbonate; )
|
|
| * |
»ó±â ÀÓºÎÅõ¿©¿¡ ´ëÇÑ Á¤º¸´Â Àü»êó¸® µÇ¸é¼ ÀÔ·Â ¿À·ù °¡´É¼ºÀÌ Á¸ÀçÇÕ´Ï´Ù. ¿À·ù °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇÏ¿© ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸³ª, ±× Á¤È®¼º¿¡ ´ëÇÏ¿© È®½ÅÀ» µå¸± ¼ö ¾ø½À´Ï´Ù. ÀÌ¿¡ ´ëÇØ ȸ»ç´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù.
|
| * |
¹Ýµå½Ã °ø½Å·Â ÀÖ´Â ¹®ÇåÀ» ´Ù½Ã Çѹø Âü°í ÇϽñ⠹ٶó¸ç ÀÇ»ç ¶Ç´Â ¾à»çÀÇ ÆÇ´Ü¿¡ µû¶ó Åõ¿©¿©ºÎ°¡ °áÁ¤µÇ¾î¾ß ÇÕ´Ï´Ù.
|
|
|
| Pharmacokinetics |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| º¸°ü»ó ÁÖÀÇ |
|
| Á¶Á¦½Ã ÁÖÀÇ |
|
|
|
 | ½É»çÁ¤º¸ |
|
|
|
|
 | ÇмúÁ¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
| DUR (ÀǾàǰ»ç¿ëÆò°¡) |
º´¿ë±Ý±â :
°í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]
¿¬·É´ë±Ý±â :
°í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
|
| µ¶¼ºÁ¤º¸ |
Calcium¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â
Ãâó: ±¹¸³µ¶¼º°úÇпø µ¶¼º¹°ÁúÁ¤º¸DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do |
| Pharmacokinetics |
Sodium BicarbonateÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
- È¿°ú ¹ßÇö ½Ã±â :
- °æ±¸ : 15ºÐ
- Á¤¸ÆÁÖ»ç : ½Å¼ÓÈ÷ ¹ßÇö
- ÀÛ¿ëÁö¼Ó ½Ã°£ :
- °æ±¸ : 1-3 ½Ã°£
- Á¤¸ÆÁÖ»ç : 8-10 ºÐ
- Èí¼ö : °æ±¸ : °æ±¸Á¦ Åõ¿©½Ã À§»êÀ» ÁßÈÇϰí ÀÌ»êÈź¼Ò¸¦ »ý¼ºÇϸç, °úµµÇÑ Áßź»êÀÌ Ç÷ÀåÀ» Èí¼öµÈ´Ù.
- ¼Ò½Ç : ½ÅÀå¿¡¼ ÀçÈí¼öµÇ¸ç, 1% ¹Ì¸¸ÀÌ ´¢¹è¼³µÊ
Precipitated calcium carbonateÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
- Èí¼ö : À§Àå°üÀ» ÅëÇØ ÀÌ¿ÂÈ ÇüÅ·ΠÈí¼öµÇ¸ç ºñŸ¹Î D°¡ ÇÊ¿ä;»ê¼º¿¡¼ Èí¼öÁõ°¡
- »ýü³»ÀÌ¿ë·ü : 4-45 %
- À½½Ä¹°ÀÇ ¿µÇâ : Ä®½·Èí¼ö(10-30 %)Áõ°¡
¼¶À¯¼Ò°¡ ¸¹Àº À½½ÄÀº À§Àå°ü ¹èÃâ½Ã°£À» Áöü½ÃÄÑ Ä®½·Èí¼ö¸¦ ÀúÇϽÃÅ´
- ºÐÆ÷ : ŹÝÅë°ú; À¯ÁóºÐºñ
- ´Ü¹é°áÇÕ : 45 %
- ¼Ò½Ç : Èí¼öµÇÁö ¾ÊÀº Ä®½·Àº ÁÖ·Î º¯À¸·Î ¹è¼³
½Å¹è¼³ : 20 % (50-300 mg/day)
|
CYP450 Drug Interaction |
[CYP450 TableÁ÷Á¢Á¶È¸]
|
|
|
 | »ç¿ëÀÚÄÁÅÙÃ÷ |
|
|
|
|
|
-
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2025-09-30
-
º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
|
|
¾Ë¸² |
»ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù. |
|
°æ°í |
µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù.
Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â
Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
|
|
¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é
¿©±â·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
|
|
|
|